Compare INBX & KRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INBX | KRP |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2024 | 2017 |
| Metric | INBX | KRP |
|---|---|---|
| Price | $92.91 | $14.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $150.00 | $17.33 |
| AVG Volume (30 Days) | 267.1K | ★ 831.7K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 10.25% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,300,000.00 | ★ $333,830,000.00 |
| Revenue This Year | N/A | $6.88 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 550.00 | 7.93 |
| 52 Week Low | $13.97 | $11.31 |
| 52 Week High | $155.29 | $15.80 |
| Indicator | INBX | KRP |
|---|---|---|
| Relative Strength Index (RSI) | 43.53 | 43.30 |
| Support Level | $71.31 | $14.10 |
| Resistance Level | $94.52 | $14.95 |
| Average True Range (ATR) | 6.37 | 0.28 |
| MACD | 0.11 | -0.08 |
| Stochastic Oscillator | 38.60 | 11.97 |
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Kimbell Royalty Partners LP owns and acquires mineral and royalty interests in oil and natural gas properties throughout the United States. The company's basins and producing regions include areas of interest in the Permian Basin, Mid-Continent, Terryville/Cotton Valley/Haynesville, Appalachian Basin, Eagle Ford, Bakken/Williston Basin, and DJ Basin/Rockies/Niobrara. Its revenues are derived from royalty payments received from operators based on the sale of oil, natural gas and NGL production, as well as the sale of NGLs that are extracted from natural gas during processing.